Zweig DiMenna Associates LLC Acquires 2,840 Shares of UnitedHealth Group Inc (UNH)

Zweig DiMenna Associates LLC increased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 4.3% in the second quarter, Holdings Channel reports. The institutional investor owned 68,714 shares of the healthcare conglomerate’s stock after purchasing an additional 2,840 shares during the quarter. UnitedHealth Group accounts for 1.0% of Zweig DiMenna Associates LLC’s portfolio, making the stock its 23rd biggest position. Zweig DiMenna Associates LLC’s holdings in UnitedHealth Group were worth $16,858,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Wells Fargo & Company MN increased its stake in UnitedHealth Group by 0.5% in the second quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock valued at $1,887,377,000 after purchasing an additional 39,480 shares in the last quarter. Alliancebernstein L.P. increased its stake in UnitedHealth Group by 1.3% in the fourth quarter. Alliancebernstein L.P. now owns 7,334,593 shares of the healthcare conglomerate’s stock valued at $1,616,984,000 after purchasing an additional 96,727 shares in the last quarter. Summit Trail Advisors LLC increased its stake in UnitedHealth Group by 19,286.4% in the first quarter. Summit Trail Advisors LLC now owns 6,228,065 shares of the healthcare conglomerate’s stock valued at $6,228,000 after purchasing an additional 6,195,939 shares in the last quarter. American Century Companies Inc. increased its position in shares of UnitedHealth Group by 3.5% during the first quarter. American Century Companies Inc. now owns 5,116,815 shares of the healthcare conglomerate’s stock worth $1,094,998,000 after acquiring an additional 173,074 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. increased its position in shares of UnitedHealth Group by 1.3% during the first quarter. Schwab Charles Investment Management Inc. now owns 3,911,833 shares of the healthcare conglomerate’s stock worth $837,133,000 after acquiring an additional 49,824 shares in the last quarter. 85.17% of the stock is owned by institutional investors and hedge funds.

In related news, insider Larry C. Renfro sold 19,652 shares of the stock in a transaction on Friday, June 15th. The shares were sold at an average price of $254.55, for a total transaction of $5,002,416.60. Following the completion of the transaction, the insider now owns 153,679 shares in the company, valued at $39,118,989.45. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the stock in a transaction on Monday, May 21st. The stock was sold at an average price of $248.82, for a total transaction of $3,732,300.00. Following the transaction, the director now owns 1,746,533 shares of the company’s stock, valued at approximately $434,572,341.06. The disclosure for this sale can be found here. Insiders have sold 59,829 shares of company stock valued at $15,190,129 in the last 90 days. 0.87% of the stock is currently owned by corporate insiders.



Several equities research analysts have recently issued reports on the stock. Goldman Sachs Group reissued a “buy” rating and set a $277.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, July 17th. Royal Bank of Canada increased their price objective on shares of UnitedHealth Group from $282.00 to $284.00 and gave the stock a “$255.42” rating in a research report on Wednesday, July 18th. ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Wednesday, May 2nd. JPMorgan Chase & Co. increased their price objective on shares of UnitedHealth Group to $266.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 18th. Finally, Oppenheimer increased their price objective on shares of UnitedHealth Group from $260.00 to $276.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 18th. Twenty-two analysts have rated the stock with a buy rating, UnitedHealth Group presently has an average rating of “Buy” and an average price target of $271.14.

Shares of UNH opened at $263.48 on Wednesday. UnitedHealth Group Inc has a 12 month low of $186.00 and a 12 month high of $264.30. The firm has a market cap of $250.59 billion, a P/E ratio of 26.16, a price-to-earnings-growth ratio of 1.55 and a beta of 0.71. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 0.63.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 17th. The healthcare conglomerate reported $3.14 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.04 by $0.10. UnitedHealth Group had a net margin of 5.55% and a return on equity of 22.79%. The business had revenue of $56.09 billion during the quarter, compared to analysts’ expectations of $56.10 billion. During the same quarter in the prior year, the company posted $2.46 earnings per share. The firm’s revenue was up 12.1% on a year-over-year basis. equities research analysts predict that UnitedHealth Group Inc will post 12.72 EPS for the current year.

UnitedHealth Group declared that its Board of Directors has approved a stock buyback program on Wednesday, June 6th that allows the company to buyback 100,000,000 shares. This buyback authorization allows the healthcare conglomerate to reacquire shares of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s management believes its stock is undervalued.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 18th. Investors of record on Friday, September 7th will be issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 1.37%. The ex-dividend date of this dividend is Thursday, September 6th. UnitedHealth Group’s payout ratio is 35.75%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: How to Use the New Google Finance Tool

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply